Similar articles for PMID: 17041098

Year	Number of Results
2001	4
2002	2
2003	1
2004	5
2005	5
2006	10
2007	5
2008	9
2009	9
2010	10
2011	9
2012	5
2013	2
2014	5
2015	5
2016	4
2017	4
2018	3
2020	2
2022	3
2023	2
2024	0

1

The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.

Azrak RG, Frank CL, Ling X, Slocum HK, Li F, Foster BA, Rustum YM. Azrak RG, et al. Mol Cancer Ther. 2006 Oct;5(10):2540-8. doi: 10.1158/1535-7163.MCT-05-0546. Mol Cancer Ther. 2006. PMID: 17041098 Free PMC article.

2

Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.

Liu X, Gao R, Dong Y, Gao L, Zhao Y, Zhao L, Zhao X, Zhang H. Liu X, et al. BMC Cancer. 2010 Aug 10;10:418. doi: 10.1186/1471-2407-10-418. BMC Cancer. 2010. PMID: 20698994 Free PMC article.

3

Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells.

Yeo JK, Cha SD, Cho CH, Kim SP, Cho JW, Baek WK, Suh MH, Kwon TK, Park JW, Suh SI. Yeo JK, et al. Cancer Lett. 2002 Aug 8;182(1):83-92. doi: 10.1016/s0304-3835(02)00075-7. Cancer Lett. 2002. PMID: 12175527

4

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.

Kucukzeybek Y, Gul MK, Cengiz E, Erten C, Karaca B, Gorumlu G, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Uslu R. Kucukzeybek Y, et al. J Exp Clin Cancer Res. 2008 Sep 12;27(1):37. doi: 10.1186/1756-9966-27-37. J Exp Clin Cancer Res. 2008. PMID: 18789152 Free PMC article.

5

Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.

Hu H, Li GX, Wang L, Watts J, Combs GF Jr, Lü J. Hu H, et al. Clin Cancer Res. 2008 Feb 15;14(4):1150-8. doi: 10.1158/1078-0432.CCR-07-4037. Clin Cancer Res. 2008. PMID: 18281549

6

Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.

Morikawa Y, Koike H, Sekine Y, Matsui H, Shibata Y, Ito K, Suzuki K. Morikawa Y, et al. Biochem Biophys Res Commun. 2012 Mar 16;419(3):584-9. doi: 10.1016/j.bbrc.2012.02.089. Epub 2012 Feb 24. Biochem Biophys Res Commun. 2012. PMID: 22387542

7

Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells.

Gomez LA, de Las Pozas A, Perez-Stable C. Gomez LA, et al. Mol Cancer Ther. 2006 May;5(5):1216-26. doi: 10.1158/1535-7163.MCT-05-0467. Mol Cancer Ther. 2006. PMID: 16731754

8

Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells.

Kim T, Jung U, Cho DY, Chung AS. Kim T, et al. Carcinogenesis. 2001 Apr;22(4):559-65. doi: 10.1093/carcin/22.4.559. Carcinogenesis. 2001. PMID: 11285189

9

Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.

Kim S, Kang J, Qiao J, Thomas RP, Evers BM, Chung DH. Kim S, et al. J Pediatr Surg. 2004 Apr;39(4):516-21. doi: 10.1016/j.jpedsurg.2003.12.008. J Pediatr Surg. 2004. PMID: 15065019

10

Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.

Park HS, Hong SK, Oh MM, Yoon CY, Jeong SJ, Byun SS, Cheon J, Lee SE, Moon du G. Park HS, et al. Anticancer Res. 2014 Jul;34(7):3457-68. Anticancer Res. 2014. PMID: 24982354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year